WHO declares $Moneypox a Public Health Emergency of International Concern and plans to roll out two vaccines

The claim is that 3.7% of cases result in death—which is higher than what was claimed for COVID at the start: 14,000 cases and 524 deaths (most in children) in 2024. This is extremely unlikely for a number of reasons.

Addendum: In the 2 hrs since the WHO announced the numbers above at its press conference today, the WHO’s numbers (in a press release) have risen: over 15,600 cases and 537 deaths.

a) This is 20 times higher than the death rate for the 2022-23 monkeypox outbreak

b) Obtaining an accurate death rate in the Democratic Republic of Congo where there are few roads and very little modern infrastructure is impossible. In fact Dr. Ogoina, chair of the WHO expert committee, said in today’s press conference that there is underreporting of cases. He also noted that some deaths were in patients with advanced HIV disease.

c). We were initially told that monkeypox had a 1-10% mortality rate in Africa, which may or may not be true, but the mortality rate in the west was more like 0.1%

Dr. Ogoina also said this is a “new form of monkeypox” with “atypical lesions”—so what we need is to look at the genome and get an idea where it came from.

Keep reading

Fatal Myocarditis following COVID-19 mRNA Immunization: A Case Report and Differential Diagnosis Review

Carditis in childhood is a rare disease with several etiologies. We report a case of infant death due to pericarditis and myocarditis after the mRNA vaccine against COVID-19 (COVIDmRNAV). A 7-year-old male child received the first dose of the COVIDmRNAV and presented with monoarthritis and a fever non-responsive to oral antibiotics. The laboratory investigation showed signs of infection (leukocytosis, high levels of c-reactive protein). His condition rapidly deteriorated, and the patient died. The autopsy identified pericardial fibrin deposits, hemorrhagic areas in the myocardium, and normal valves. A diffuse intermyocardial inflammatory infiltrate composed of T CD8+ lymphocytes and histiocytes was identified. An antistreptolysin O (ASO) dosage showed high titers. The presence of arthritis, elevated ASO, and carditis fulfills the criteria for rheumatic fever. However, valve disease and Aschoff’s nodules, present in 90% of rheumatic carditis cases, were absent in this case. The temporal correlation with mRNA vaccination prompted its inclusion as one of the etiologies. In cases of myocardial damage related to COVID-19mRNAV, it appears to be related to the expression of exosomes and lipid nanoparticles, leading to a cytokine storm. The potential effects of the COVID-19mRNAV must be considered in the pathogenesis of this disease, whether as an etiology or a contributing factor to a previously initiated myocardial injury.

Keep reading

Dr. Fauci Reveals He’s Infected With COVID For Third Time After Being “Vaccinated and Boosted Six Times”

Dr. Anthony Fauci revealed that he’s been infected with COVID for a third time despite having been “vaccinated and boosted six times.”

Yes, really.

The former chief medical advisor to the president, who became the face of the COVID vaccination drive from late 2020 onwards, reacted to catching COVID-19 yet again by thanking the vaccine.

“I got infected about two weeks ago, it was my third infection, and I have been vaccinated and boosted a total of six times,” said Fauci.

Fauci, who back in 2021 said, “If you get vaccinated, you are protected,” seemingly hasn’t been protected from catching the virus despite receiving half a dozen vaccines.

He also separately asserted during the same year, “When people get vaccinated, they can feel safe that they are not gonna get infected.”

Keep reading

It’s not just the MMR vaccine that triggers autism

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterised by difficulties in social interaction, communication, and restricted or repetitive behaviours. The exact causes of autism remain unclear, but extensive research points to a combination of genetic and environmental risk factors that influence early brain development. In addition, known triggers of autism are communicated by the mother’s of autistic children, the most common being vaccines.

Genetic Factors in Autism

Whilst twin and family studies have consistently shown that autism has a strong genetic component, it is clearly influenced by environmental factors. A meta-analysis of twin studies estimated the heritability of ASD to be between 64% and 91%, indicating that genetic differences account for a substantial proportion of the likelihood of developing autism. Siblings of individuals with ASD have a 10-20 times higher risk of also being diagnosed compared to the general population .

While ASD is highly heritable, its genetic architecture is complex, involving a combination of rare and common genetic variants [2,3]. Rare mutations, including copy number variants (CNVs) and single nucleotide variants (SNVs), are found in 10-30% of individuals with ASD and often have a large effect size . Common variants, such as single nucleotide polymorphisms (SNPs), individually have small effects but cumulatively can contribute to a significant proportion of ASD risk [2,3]. Genetic studies have implicated hundreds of genes in ASD, many of which are involved in key processes like synaptic function, transcriptional regulation, and chromatin remodelling [2,3]. However, translating these genetic findings into clinical practice remains challenging due to the heterogeneity of ASD genetics and the variable expressivity and penetrance of identified variants .

Environmental Factors

While genes play a major role, environmental factors also contribute to the development of ASD, likely through complex interactions with genetic susceptibility. Several prenatal and perinatal exposures have been associated with increased autism risk, including parental age, air pollution, maternal infections and immune activation, maternal metabolic conditions, pregnancy and birth complications, drugs and medications

Both older maternal and paternal age at conception are linked to higher rates of ASD. A meta-analysis found that mothers over 35 had a 1.5 times higher odds of having a child with ASD compared to mothers aged 25-29 . Advancing paternal age over 40 also confers increased risk, possibly due to the accumulation of de novo mutations in sperm .

Exposure to traffic-related air pollution, particularly particulate matter, during pregnancy and early life has been associated with ASD . A study in California found that children living in areas with the highest levels of traffic-related air pollution were 3 times more likely to be diagnosed with ASD .

Maternal influenza infection, prolonged fever, and autoimmune conditions during pregnancy may increase the likelihood of ASD in offspring, potentially by altering foetal brain development . In the CHARGE study, mothers who reported influenza or fever lasting over one week had a 2-fold increased risk of having a child with ASD. Diabetes, hypertension, and obesity during pregnancy have been linked to elevated autism risk. A study found that mothers with gestational diabetes had a 1.4 times higher chance of having a child with ASD, while pre-pregnancy obesity conferred a 1.6 times greater risk . Preterm birth, low birth weight, and neonatal hypoxia have shown associations with ASD [8,9]. In a study of ex-preterm infants, those who screened positive for ASD had higher rates of low birth weight, neonatal seizures, and brain abnormalities on MRI .

The use of valproic acid, an anticonvulsant and mood stabiliser, during pregnancy has been associated with a 3-5 fold increased risk of ASD in offspring . Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) has also been suggested to influence ASD risk, although evidence is mixed . It’s important to note that these exposures show an association, not necessarily a causal link, with ASD. Most children exposed to these risk factors do not develop autism, and conversely, many children with ASD have no known environmental exposures. The timing, duration, and intensity of exposures likely interact with genetic predisposition in complex ways .

Rather than acting in isolation, genetic and environmental factors probably combine to influence ASD risk through gene-environment interactions. Certain environmental exposures may have different effects depending on an individual’s genetic background. For example, some studies suggest that prenatal vitamin supplementation or higher folate intake may reduce ASD risk, but this protective effect may depend on the mother’s and child’s genotype related to folate metabolism . Variants in genes involved in detoxification and immune function could also modify the effects of toxicant and infection exposures .

Keep reading

Judges Back Meta in Vaccine “Misinformation” Battle, Free Speech Advocates Vow to Fight On

The 9th Circuit US Court of Appeals ruled this week in favor of Meta, Facebook’s parent company. The case was brought forward by the Children’s Health Defense (CHD) over allegations that the social media giant violated free speech rights.

The lawsuit, initiated in August 2020 and later updated in December, claimed that Facebook, along with its CEO Mark Zuckerberg and two fact-checking entities, Science Feedback, and the Poynter Institute’s PolitiFact site, was complicit in an unconstitutional act of privately exercising governmental censorship. CHD alleges that Facebook, in collaboration with the Centers for Disease Control and Prevention (CDC) and other federal institutions, is censoring content and discussions that the government is barred from suppressing under the First Amendment.

We obtained a copy of the opinion for you here.

The plaintiff specifically accused these sides of working in tandem to unfairly stifle valid attempts to discuss vaccine safety on Facebook, often through indirect yet sensorial measures like the use of warning labels. According to CHD, this type of arrangement between public entities and private corporations represents a breach of the First Amendment due to its perceived status as “state action.”

Keep reading

WHO Triggers Emergency Use Listing for Monkeypox Vaccines

The World Health Organization (WHO) today triggered the process to grant Emergency Use Listing to two monkeypox vaccines.

WHO Director-General Tedros Adhanom Ghebreyesus told the media the listing will accelerate vaccine access in lower-income countries that have not yet approved the drugs.

“Emergency Use Listing also enables partners including Gavi and UNICEF to procure vaccines for distribution,” Tedros said. He also said he would convene an expert group to determine if the spread of monkeypox — renamed mpox — in Africa should be declared a global emergency.

Gavi, the Vaccine Alliance and UNICEF are funded in part by the Bill & Melinda Gates Foundation.

The WHO uses the Emergency Use Listing process to help member states that haven’t already authorized unlicensed vaccines, therapeutics and tests speed up their processes for authorizing them.

During the COVID-19 pandemic Emergency Use Listing was a key mechanism used by member states without structures for granting emergency use authorization to drugs to authorize and distribute the vaccines, working together with the WHO, Gavi and UNICEF, Unlimited Hangout’s Max Jones reported.

Tedros said the Emergency Use Listing helps those same partners procure vaccines for distribution, and that countries like Japan, the U.S. and the European Union are supporting the effort through donations.

He said the Democratic Republic of the Congo is experiencing a severe outbreak of mpox, with 14,000 cases and 511 deaths. Although cases have existed there for decades, the numbers are rising and spreading to new provinces, he said.

Keep reading

Paper showing COVID and flu vaccines do NOT reduce hospitalization was published today

Today was a good day.

Two breakthroughs:

  1. My paper showing the COVID and flu vaccines do not work was published in PrePrints today. The paper shows that the COVID and flu vaccines don’t reduce hospitalization at all. Zero. Zip. Nada. It uses VA data published in JAMA by a top epidemiologist to expose the truth. No hospitalization benefit implies no death benefit because there is no precedent in medicine for no hospitalization benefit yielding a death benefit. So they lied to us about the benefits. It was ALL downside risk with the shots.
  2. I was able to confirm that the Medicare data shows that the mortality rate of the shots depends on brand. Statistically significant. Yet, nobody in the world is looking at this. Not at the local level, not the state level, not the national level. They all look the other way. I guess it’s time for another paper?

Keep reading

The virus was safer than the vaccine. Whoops!

A quick summary of what we know so far

  1. The COVID vaccines were all downside risk for no benefit. The vaccine provided no protection against hospitalization or death, and actually increased your risk of getting COVID. So there was no benefit whatsoever.They all (except maybe Novavax) increased your all-cause mortality, something a vaccine is never supposed to do.
  2. Virus safer than the shots. The adverse event profile is, in general, much higher for those taking the jabs than for those infected with COVID.
  3. The medical community is willfully blind to the harms. It is appalling that the medical literature refuses to accept 1 and 2.
  4. COVID shots are not equally safe, but nobody will publish the relative brand safety data. There are significant mortality differences between the vaccine brands. It is beyond shameful that none of the health authorities anywhere in the world will expose the numbers or even want to see them. Hiding that safety information is not in the public interest.
  5. They need to stop hiding the data. As long as they keep the record level data secret on vaccines and mortality, nobody should take them.
  6. They need to acknowledge that fully unvaccinated kids are healthier. Every study in the peer-reviewed literature shows fully unvaccinated kids are healthier than their fully vaccinated counterparts.
  7. Vaccines are the primary cause of autism and a large number of chronic disorders. The data also points very strongly that vaccines are the major cause of sexual orientation and gender dysphoria conditions. A lot of people can’t accept that but the data is stunning and cannot be explained away.
  8. It’s hard to get the truth published nowadays. It is ridiculously hard to get a paper published in a peer-reviewed journal that goes against mainstream beliefs.
  9. The Czech Republic data where we found that Moderna increases all-cause mortality by 30%. If that’s wrong, what’s the right number and how come nobody knows what it is?
  10. You can’t keep hiding the truth. Sooner or later, however, we will see papers emerge that validate everything I’ve said above. I just can’t predict when that will happen.

Keep reading

World-Renowned Vaccinologist Publishes Paper Admitting Lack of Vaccine Safety Studies

In a stunning reversal, Dr. Stanley Plotkin, widely regarded as the godfather of modern vaccinology, has co-authored a paper in the New England Journal of Medicine1 (NEJM) acknowledging significant gaps in vaccine safety research and calling for increased funding to address these shortcomings.

This admission comes after decades of the medical establishment insisting that vaccines are among the most thoroughly studied and safest medical interventions. In the paper, titled “Funding Postauthorization Vaccine-Safety Science,”2 they make a series of revelations that validate concerns long raised by vaccine safety advocates. In a commentary, Aaron Siri, managing partner of New York law firm Siri & Glimstad, writes:3

“Wow. After decades of Dr. Stanley Plotkin and his vaccinologist disciples insisting vaccines are the most well studied products on the planet, they just penned an article admitting precisely the opposite.

They just admitted vaccines are not properly studied — neither prelicensure nor post-licensure. They admitted, for example, ‘prelicensure clinical trials have limited sample sizes [and] follow-up durations’ and that ‘there are not resources earmarked for postauthorization safety studies.'”

Key Admissions Shine Light on Lack of Vaccine Safety Studies

One of the most striking admissions in the paper is the acknowledgment that prelicensure clinical trials for vaccines are inadequate for assessing safety. The authors state:4

“Postauthorization studies are needed to fully characterize the safety profile of a new vaccine, since prelicensure clinical trials have limited sample sizes, follow-up durations, and population heterogeneity. It is critical to examine adverse events following immunization (AEFIs) that have not been detected in clinical trials, to ascertain whether they are causally or coincidentally related to vaccination.”

This contradicts previous claims by vaccine proponents that clinical trials provide robust evidence of safety prior to approval. The admission that these trials have limited follow-up periods is particularly notable, as critics have long argued that potential long-term effects of vaccines are not adequately studied before they are approved and recommended for widespread use.

“Let me translate,” Siri writes, “the clinical trials relied upon to license childhood vaccines are useless with regard to safety since they virtually never have a placebo control, typically review safety for days or weeks after injection, and often have far too few participants to measure anything of value.”5

Keep reading

Meta-Analysis Finds Massive Failure of COVID-19 Vaccines to Stop SARS-CoV-2

Virtually every vaccinated person I meet has contracted COVID-19. Many still believe vaccination was worth the risk because they did not end up in the hospital in 2021 through the present day. Vaccine-takers tended to be younger working age individuals who were mandated by work or school, and therefore healthier than those not forced into taking the jab. In my practice, the senior citizens who took the vaccine tended to be healthier and far more worried about COVID-19. They were the first to get early treatment for the illness. Finally, we all saw COVID-19 illness become far milder on the second, third, and fourth infections because of natural immunity as we were faced with milder strains. So in the midst of this confounded set of relationships, how did the COVID-19 vaccines perform?

Wu et al, published a meta-analysis of 68 studies evaluating efficacy of COVID-19 vaccination. Keep in mind only favorable studies were accepted by editors. The results indicate a stunning failure of vaccination. Because the data are not from high-quality, prospective, double-blind, placebo-controlled, randomized trials, and publication bias, we must be conservative and consider the lower-bound of the confidence interval as the statistic of interest. This means that vaccine performance could be as bad as that number.

Keep reading